These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
461 related articles for article (PubMed ID: 9074848)
1. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Coukell AJ; Spencer CM Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848 [TBL] [Abstract][Full Text] [Related]
2. Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Sharpe M; Easthope SE; Keating GM; Lamb HM Drugs; 2002; 62(14):2089-126. PubMed ID: 12269857 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. Northfelt DW; Dezube BJ; Thommes JA; Levine R; Von Roenn JH; Dosik GM; Rios A; Krown SE; DuMond C; Mamelok RD J Clin Oncol; 1997 Feb; 15(2):653-9. PubMed ID: 9053490 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. Amantea MA; Forrest A; Northfelt DW; Mamelok R Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455 [TBL] [Abstract][Full Text] [Related]
5. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. Northfelt DW; Martin FJ; Working P; Volberding PA; Russell J; Newman M; Amantea MA; Kaplan LD J Clin Pharmacol; 1996 Jan; 36(1):55-63. PubMed ID: 8932544 [TBL] [Abstract][Full Text] [Related]
6. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358 [TBL] [Abstract][Full Text] [Related]
7. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415 [TBL] [Abstract][Full Text] [Related]
8. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796 [TBL] [Abstract][Full Text] [Related]
9. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. Northfelt DW; Dezube BJ; Thommes JA; Miller BJ; Fischl MA; Friedman-Kien A; Kaplan LD; Du Mond C; Mamelok RD; Henry DH J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262 [TBL] [Abstract][Full Text] [Related]
10. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092 [TBL] [Abstract][Full Text] [Related]
11. Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Duggan ST; Keating GM Drugs; 2011 Dec; 71(18):2531-58. PubMed ID: 22141391 [TBL] [Abstract][Full Text] [Related]
12. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Gabizon A; Martin F Drugs; 1997; 54 Suppl 4():15-21. PubMed ID: 9361957 [TBL] [Abstract][Full Text] [Related]
13. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group. Goebel FD; Goldstein D; Goos M; Jablonowski H; Stewart JS Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437 [TBL] [Abstract][Full Text] [Related]
17. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Gabizon AA Cancer Invest; 2001; 19(4):424-36. PubMed ID: 11405181 [TBL] [Abstract][Full Text] [Related]
18. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma. Simpson JK; Miller RF; Spittle MF Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358 [TBL] [Abstract][Full Text] [Related]
19. Use of liposomal anthracyclines in Kaposi's sarcoma. Krown SE; Northfelt DW; Osoba D; Stewart JS Semin Oncol; 2004 Dec; 31(6 Suppl 13):36-52. PubMed ID: 15717737 [TBL] [Abstract][Full Text] [Related]
20. Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma. Udhrain A; Skubitz KM; Northfelt DW Int J Nanomedicine; 2007; 2(3):345-52. PubMed ID: 18019833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]